Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

A Study of Patient Satisfaction and Uncertainty in a Rapid Access Chest Pain Clinic.

Lembo RJ, Gullick J, Chow CK, Figtree GA, Kozor R.

Heart Lung Circ. 2020 Mar 7. pii: S1443-9506(20)30064-0. doi: 10.1016/j.hlc.2020.01.016. [Epub ahead of print]

PMID:
32192829
2.

Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarction.

Thavapalachandran S, Grieve SM, Hume RD, Le TYL, Raguram K, Hudson JE, Pouliopoulos J, Figtree GA, Dye RP, Barry AM, Brown P, Lu J, Coffey S, Kesteven SH, Mills RJ, Rashid FN, Taran E, Kovoor P, Thomas L, Denniss AR, Kizana E, Asli NS, Xaymardan M, Feneley MP, Graham RM, Harvey RP, Chong JJH.

Sci Transl Med. 2020 Jan 1;12(524). pii: eaay2140. doi: 10.1126/scitranslmed.aay2140.

PMID:
31894101
3.

Metabolites downstream of predicted loss-of-function variants inform relationship to disease.

Li M, Wang A, Quek LE, Vernon S, Figtree GA, Yang J, O'Sullivan JF.

Mol Genet Metab. 2019 Dec;128(4):476-482. doi: 10.1016/j.ymgme.2019.10.002. Epub 2019 Oct 17.

PMID:
31679996
4.

Mediators of the Effects of Canagliflozin on Heart Failure in Patients With Type 2 Diabetes.

Li J, Woodward M, Perkovic V, Figtree GA, Heerspink HJL, Mahaffey KW, de Zeeuw D, Vercruysse F, Shaw W, Matthews DR, Neal B.

JACC Heart Fail. 2020 Jan;8(1):57-66. doi: 10.1016/j.jchf.2019.08.004. Epub 2019 Oct 29.

5.

ST-Segment-Elevation Myocardial Infarction (STEMI) Patients Without Standard Modifiable Cardiovascular Risk Factors-How Common Are They, and What Are Their Outcomes?

Vernon ST, Coffey S, D'Souza M, Chow CK, Kilian J, Hyun K, Shaw JA, Adams M, Roberts-Thomson P, Brieger D, Figtree GA.

J Am Heart Assoc. 2019 Nov 5;8(21):e013296. doi: 10.1161/JAHA.119.013296. Epub 2019 Nov 1.

6.

Silent left ventricular apical ballooning and Takotsubo cardiomyopathy in an Australian intensive care unit.

Rowell AC, Stedman WG, Janin PF, Diel N, Ward MR, Kay SM, Delaney A, Figtree GA.

ESC Heart Fail. 2019 Dec;6(6):1262-1265. doi: 10.1002/ehf2.12517. Epub 2019 Sep 26.

7.

Biobanking for discovery of novel cardiovascular biomarkers using imaging-quantified disease burden: protocol for the longitudinal, prospective, BioHEART-CT cohort study.

Kott KA, Vernon ST, Hansen T, Yu C, Bubb KJ, Coffey S, Sullivan D, Yang J, O'Sullivan J, Chow C, Patel S, Chong J, Celermajer DS, Kritharides L, Grieve SM, Figtree GA.

BMJ Open. 2019 Sep 18;9(9):e028649. doi: 10.1136/bmjopen-2018-028649.

8.

Tackling Disparities in Heart Care and Disease Outcomes in Women: Insights and Highlights From the Women and Heart Disease Forum.

Arnott C, Parsonage WA, Figtree GA.

Heart Lung Circ. 2019 Oct;28(10):1449-1451. doi: 10.1016/j.hlc.2019.08.001. No abstract available.

PMID:
31495500
9.

Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study.

Zbinden R, Wollmann C, Brachmann J, Michaelsen J, Steinwender C, Kovoor P, Kelle S, McGavigan AD, Ching CK, Figtree GA, Schmidt J, Timmel T, Lotz J.

Europace. 2019 Nov 1;21(11):1678-1685. doi: 10.1093/europace/euz189.

10.

New opportunities for targeting redox dysregulation in cardiovascular disease.

Bubb KJ, Drummond GR, Figtree GA.

Cardiovasc Res. 2020 Mar 1;116(3):532-544. doi: 10.1093/cvr/cvz183.

PMID:
31297507
11.

Building an Academic-Industry Partnership to Tackle Australia's Biggest Health Burden.

Climie RE, Kingwell BA, Figtree GA.

Heart Lung Circ. 2019 Aug;28(8):1144-1147. doi: 10.1016/j.hlc.2019.05.174.

PMID:
31230791
12.

A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice.

Vijapurapu R, Kozor R, Hughes DA, Woolfson P, Jovanovic A, Deegan P, Rusk R, Figtree GA, Tchan M, Whalley D, Kotecha D, Leyva F, Moon J, Geberhiwot T, Steeds RP.

Trials. 2019 May 31;20(1):314. doi: 10.1186/s13063-019-3425-1.

13.

Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus.

Figtree GA, Rådholm K, Barrett TD, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Matthews DR, Shaw W, Neal B.

Circulation. 2019 May 28;139(22):2591-2593. doi: 10.1161/CIRCULATIONAHA.119.040057. Epub 2019 Mar 17. No abstract available.

14.

The Australian Cardiovascular Alliance-Towards an Integrated Whole-of-Nation Strategy to Address Our Major Health Burden.

Figtree GA, Jennings G, Nicholls S, Graham RM.

Heart Lung Circ. 2019 Feb;28(2):198-203. doi: 10.1016/j.hlc.2018.12.002. No abstract available.

PMID:
30654944
15.

Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)".

Figtree GA, Rådholm K, Neal B.

Circulation. 2019 Jan 15;139(3):418-419. doi: 10.1161/CIRCULATIONAHA.118.038477. No abstract available.

16.

Testosterone to estradiol ratio and plaque inflammation: mechanistic insights and biomarker potential?

Figtree GA, Ngo DTM, Bubb KJ.

Cardiovasc Res. 2019 Feb 1;115(2):255-257. doi: 10.1093/cvr/cvy260. No abstract available.

PMID:
30395210
17.

Modified redox signaling in vasculature after chronic infusion of the insulin receptor antagonist, S961.

Bubb KJ, Ritchie RH, Figtree GA.

Microcirculation. 2019 Feb;26(2):e12501. doi: 10.1111/micc.12501. Epub 2018 Oct 10.

PMID:
30178465
18.

Stem Cell-Derived Cardiac Spheroids as 3D In Vitro Models of the Human Heart Microenvironment.

Campbell M, Chabria M, Figtree GA, Polonchuk L, Gentile C.

Methods Mol Biol. 2019;2002:51-59. doi: 10.1007/7651_2018_187.

PMID:
30159827
19.

Utilizing state-of-the-art "omics" technology and bioinformatics to identify new biological mechanisms and biomarkers for coronary artery disease.

Vernon ST, Hansen T, Kott KA, Yang JY, O'Sullivan JF, Figtree GA.

Microcirculation. 2019 Feb;26(2):e12488. doi: 10.1111/micc.12488. Epub 2018 Jul 23. Review.

PMID:
29956866
20.

Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis.

Figtree GA, Bubb KJ, Tang O, Kizana E, Gentile C.

Cells Tissues Organs. 2017;204(3-4):191-198. doi: 10.1159/000477436. Epub 2017 Aug 4.

PMID:
28772272
21.

Hypoxia-Responsive Cobalt Complexes in Tumor Spheroids: Laser Ablation Inductively Coupled Plasma Mass Spectrometry and Magnetic Resonance Imaging Studies.

O'Neill ES, Kaur A, Bishop DP, Shishmarev D, Kuchel PW, Grieve SM, Figtree GA, Renfrew AK, Bonnitcha PD, New EJ.

Inorg Chem. 2017 Aug 21;56(16):9860-9868. doi: 10.1021/acs.inorgchem.7b01368. Epub 2017 Aug 2.

PMID:
28766939
22.

Increasing proportion of ST elevation myocardial infarction patients with coronary atherosclerosis poorly explained by standard modifiable risk factors.

Vernon ST, Coffey S, Bhindi R, Soo Hoo SY, Nelson GI, Ward MR, Hansen PS, Asrress KN, Chow CK, Celermajer DS, O'Sullivan JF, Figtree GA.

Eur J Prev Cardiol. 2017 Nov;24(17):1824-1830. doi: 10.1177/2047487317720287. Epub 2017 Jul 13.

PMID:
28703626
23.

Late gadolinium enhancement does occur in Tako-tsubo cardiomyopathy - A quantitative cardiac magnetic resonance and speckle tracking strain study.

Gaikwad N, Butler T, Maxwell R, Shaw E, Strugnell WE, Chan J, Figtree GA, Slaughter RE, Hamilton-Craig C.

Int J Cardiol Heart Vasc. 2016 Aug 3;12:68-74. doi: 10.1016/j.ijcha.2016.07.009. eCollection 2016 Sep.

24.

Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat.

Tate M, Deo M, Cao AH, Hood SG, Huynh K, Kiriazis H, Du XJ, Julius TL, Figtree GA, Dusting GJ, Kaye DM, Ritchie RH.

Diab Vasc Dis Res. 2017 Sep;14(5):423-433. doi: 10.1177/1479164117710390. Epub 2017 May 31.

PMID:
28565941
25.

The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling.

Bubb KJ, Kok C, Tang O, Rasko NB, Birgisdottir AB, Hansen T, Ritchie R, Bhindi R, Reisman SA, Meyer C, Ward K, Karimi Galougahi K, Figtree GA.

Free Radic Biol Med. 2017 Jul;108:585-594. doi: 10.1016/j.freeradbiomed.2017.04.027. Epub 2017 Apr 21.

PMID:
28438659
26.

Mortality, rehospitalizations and costs in children undergoing a cardiac procedure in their first year of life in New South Wales, Australia.

Lawley CM, Lain SJ, Figtree GA, Sholler GF, Winlaw DS, Roberts CL.

Int J Cardiol. 2017 Aug 15;241:156-162. doi: 10.1016/j.ijcard.2017.03.113. Epub 2017 Mar 27.

PMID:
28385359
27.

Redox modification of caveolar proteins in the cardiovascular system- role in cellular signalling and disease.

Bubb KJ, Birgisdottir AB, Tang O, Hansen T, Figtree GA.

Free Radic Biol Med. 2017 Aug;109:61-74. doi: 10.1016/j.freeradbiomed.2017.02.012. Epub 2017 Feb 7. Review.

PMID:
28188926
28.

4D flow magnetic resonance imaging: role in pediatric congenital heart disease.

Lawley CM, Broadhouse KM, Callaghan FM, Winlaw DS, Figtree GA, Grieve SM.

Asian Cardiovasc Thorac Ann. 2018 Jan;26(1):28-37. doi: 10.1177/0218492317694248. Epub 2017 Feb 10. Review.

PMID:
28185475
29.

Impact of obesity and epicardial fat on early left atrial dysfunction assessed by cardiac MRI strain analysis.

Evin M, Broadhouse KM, Callaghan FM, McGrath RT, Glastras S, Kozor R, Hocking SL, Lamy J, Redheuil A, Kachenoura N, Fulcher GR, Figtree GA, Grieve SM.

Cardiovasc Diabetol. 2016 Dec 22;15(1):164. doi: 10.1186/s12933-016-0481-7.

30.
31.

Quantifying right atrial filling and emptying: A 4D-flow MRI study.

Callaghan FM, Arnott C, Figtree GA, Kutty S, Celermajer DS, Grieve SM.

J Magn Reson Imaging. 2017 Apr;45(4):1046-1054. doi: 10.1002/jmri.25457. Epub 2016 Sep 14.

PMID:
27626621
32.

Insight into hypertrophied hearts: a cardiovascular magnetic resonance study of papillary muscle mass and T1 mapping.

Kozor R, Nordin S, Treibel TA, Rosmini S, Castelletti S, Fontana M, Captur G, Baig S, Steeds RP, Hughes D, Manisty C, Grieve SM, Figtree GA, Moon JC.

Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1034-1040. doi: 10.1093/ehjci/jew187.

PMID:
27590835
33.

Interplay between Oxidative Stress and Inflammation in Cardiometabolic Syndrome.

Sverdlov AL, Figtree GA, Horowitz JD, Ngo DT.

Mediators Inflamm. 2016;2016:8254590. doi: 10.1155/2016/8254590. Epub 2016 Aug 2. No abstract available.

34.

β3 Adrenergic Stimulation Restores Nitric Oxide/Redox Balance and Enhances Endothelial Function in Hyperglycemia.

Karimi Galougahi K, Liu CC, Garcia A, Gentile C, Fry NA, Hamilton EJ, Hawkins CL, Figtree GA.

J Am Heart Assoc. 2016 Feb 19;5(2). pii: e002824. doi: 10.1161/JAHA.115.002824.

35.

Cardiac involvement in genotype-positive Fabry disease patients assessed by cardiovascular MR.

Kozor R, Grieve SM, Tchan MC, Callaghan F, Hamilton-Craig C, Denaro C, Moon JC, Figtree GA.

Heart. 2016 Feb 15;102(4):298-302. doi: 10.1136/heartjnl-2015-308494. Epub 2016 Jan 4.

PMID:
26729695
36.

Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study.

Seneviratne MG, Grieve SM, Figtree GA, Garsia R, Celermajer DS, Adelstein S, Puranik R.

Lupus. 2016 May;25(6):573-81. doi: 10.1177/0961203315622275. Epub 2015 Dec 23.

PMID:
26700183
37.

Significance of left atrial appendage filling defects on cardiac CT prior to pulmonary vein isolation for atrial fibrillation.

Madan A, Yan W, Byrne P, Ward M, Hansen P, Whalley D, Kanagaratnam L, Figtree GA.

Int J Cardiol. 2016 Jan 15;203:520-2. doi: 10.1016/j.ijcard.2015.10.201. Epub 2015 Oct 28. No abstract available.

PMID:
26559759
38.

Current state of knowledge on Takotsubo syndrome: a Position Statement from the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology.

Lyon AR, Bossone E, Schneider B, Sechtem U, Citro R, Underwood SR, Sheppard MN, Figtree GA, Parodi G, Akashi YJ, Ruschitzka F, Filippatos G, Mebazaa A, Omerovic E.

Eur J Heart Fail. 2016 Jan;18(1):8-27. doi: 10.1002/ejhf.424. Epub 2015 Nov 9. Review.

39.

Statin Therapy and Cognition in Older People: What is the Evidence?

Gnjidic D, Naganathan V, Freedman SB, Beer CE, McLachlan AJ, Figtree GA, Hilmer SN.

Curr Clin Pharmacol. 2015;10(3):185-93. Review.

PMID:
26338171
40.

Use of multi-velocity encoding 4D flow MRI to improve quantification of flow patterns in the aorta.

Callaghan FM, Kozor R, Sherrah AG, Vallely M, Celermajer D, Figtree GA, Grieve SM.

J Magn Reson Imaging. 2016 Feb;43(2):352-63. doi: 10.1002/jmri.24991. Epub 2015 Jun 30.

PMID:
26130421
41.

Prosthetic heart valves in pregnancy, outcomes for women and their babies: a systematic review and meta-analysis.

Lawley CM, Lain SJ, Algert CS, Ford JB, Figtree GA, Roberts CL.

BJOG. 2015 Oct;122(11):1446-55. doi: 10.1111/1471-0528.13491. Epub 2015 Jun 29. Review.

42.

Routine aspiration thrombectomy improves the diagnosis and management of embolic myocardial infarction.

Huang AL, Murphy JC, Shaw E, Kozor R, Yan W, Loxton A, Soo Hoo SY, Figtree GA, Rasmussen HH, Hansen PS, Nelson GI, Bhindi R, Ward MR.

Catheter Cardiovasc Interv. 2016 Mar;87(4):642-7. doi: 10.1002/ccd.26047. Epub 2015 Jun 23.

PMID:
26105814
43.

4D Multi-VENC Cardiac MRI: Characterisation of a Functional Stenosis of the Ascending Aorta.

Kozor R, Callaghan FM, Nelson GI, Figtree GA, Grieve SM.

Heart Lung Circ. 2015 Nov;24(11):1134-5. doi: 10.1016/j.hlc.2015.04.181. Epub 2015 May 27. No abstract available.

PMID:
26092750
44.

Stimulation of the cardiac myocyte Na+-K+ pump due to reversal of its constitutive oxidative inhibition.

Chia KK, Liu CC, Hamilton EJ, Garcia A, Fry NA, Hannam W, Figtree GA, Rasmussen HH.

Am J Physiol Cell Physiol. 2015 Aug 15;309(4):C239-50. doi: 10.1152/ajpcell.00392.2014. Epub 2015 Jun 17.

45.

β3-Adrenoceptor activation relieves oxidative inhibition of the cardiac Na+-K+ pump in hyperglycemia induced by insulin receptor blockade.

Karimi Galougahi K, Liu CC, Garcia A, Fry NA, Hamilton EJ, Figtree GA, Rasmussen HH.

Am J Physiol Cell Physiol. 2015 Sep 1;309(5):C286-95. doi: 10.1152/ajpcell.00071.2015. Epub 2015 Jun 10.

46.

A disproportionate contribution of papillary muscles and trabeculations to total left ventricular mass makes choice of cardiovascular magnetic resonance analysis technique critical in Fabry disease.

Kozor R, Callaghan F, Tchan M, Hamilton-Craig C, Figtree GA, Grieve SM.

J Cardiovasc Magn Reson. 2015 Feb 21;17:22. doi: 10.1186/s12968-015-0114-4.

47.

Redox biomarkers in cardiovascular medicine.

Karimi Galougahi K, Antoniades C, Nicholls SJ, Channon KM, Figtree GA.

Eur Heart J. 2015 Jul 1;36(25):1576-82, 1582a-b. doi: 10.1093/eurheartj/ehv126. Epub 2015 Apr 16. Review.

PMID:
25888005
48.

The effect of coronary artery plaque composition, morphology and burden on Absorb bioresorbable vascular scaffold expansion and eccentricity - A detailed analysis with optical coherence tomography.

Shaw E, Allahwala UK, Cockburn JA, Hansen TC, Mazhar J, Figtree GA, Hansen PS, Bhindi R.

Int J Cardiol. 2015 Apr 1;184:230-6. doi: 10.1016/j.ijcard.2015.01.033. Epub 2015 Jan 26.

PMID:
25723650
49.

Comparison of two dimensional quantitative coronary angiography (2D-QCA) with optical coherence tomography (OCT) in the assessment of coronary artery lesion dimensions.

Mazhar J, Shaw E, Allahwala UK, Figtree GA, Bhindi R.

Int J Cardiol Heart Vasc. 2015 Jan 29;7:14-17. doi: 10.1016/j.ijcha.2015.01.011. eCollection 2015 Jun 1.

50.

Health outcomes of infants born to women with heart valve prostheses: complications of prematurity alone?

Lawley CM, Lain SJ, Figtree GA, Roberts CL.

J Matern Fetal Neonatal Med. 2016;29(2):234-6. doi: 10.3109/14767058.2014.995082. Epub 2014 Dec 24.

PMID:
25483418

Supplemental Content

Loading ...
Support Center